Scoliosis: a journal dedicated to multidisciplinary research on prevention, control, and treatment of scoliosis and other spinal deformities

Scoliosis is dedicated to multidisciplinary research on prevention, control, and treatment of scoliosis and other spinal deformities. Scoliosis was described in the Hippocratic Collection (500 B.C.) and has clinical implications for a wide range of disciplines, including biomechanics, epidemiology, exercise physiology, physical therapy, orthopaedics, osteopathy, physiatry, psychology, and respiratory science. The following contributions are welcome: research, reviews, methodology articles, and case reports. The journal will also publish "technical notes" that focus on new technical developments in the field of physiotherapy, rehabilitation and orthotics.Scoliosis is published by BioMed Central, an independent publisher committed to ensuring peer-reviewed biomedical research is open access. Articles will be freely and universally accessible online, and archived in several internationally recognized free access repositories, including PubMed Central, the US National Library of Medicine's full-text repository of life science literature, and repositories at the University of Potsdam in Germany, at INIST in France, and in e-Depot, the National Library of the Netherlands' digital archive of all electronic publications. Authors publishing in the journal retain copyright, allowing anyone to reproduce or disseminate articles, according to the BioMed Central copyright and license agreement.Scoliosis will be a valuable resource in the field of conservative scoliosis therapy. The prevalence of mild to moderate scoliosis in adolescents is 3000–5000 per 100,000 population, and in adults as high as 12% [1,2]. Fortunately, only a small minority of cases (<1%) progress to a magnitude at which spinal fusion surgery is recommended [1,3]. Treatment indications for the remaining patients, as well as those individuals with severe scoliosis who decline surgery, have been a source of controversy [4,5]. Yet the lifetime disease burden for scoliosis patients has become increasingly clear [6-